News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Drug Product News (World)
Sobi: Elocta Obtains National Reimbursement In Spain, Now Available In The Five Largest Markets In The EU 9/23/2016
35 U.S. States Sue British Drugmaker Indivior Over Marketing of Opioid 9/23/2016
Allergan (AGN) And Adamas Pharma (ADMS) Announce U.S. Availability Of New Dosage Strengths For NAMZARIC (Memantine And Donepezil Hydrochlorides) Extended Release For The Treatment Of Moderate To Severe Alzheimer's Disease 9/22/2016
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Injection In The U.S. Market 9/19/2016
Baxter International (BAX) Launches NUMETA G13E In Europe: Only Ready-To-Use IV Nutrition For Vulnerable Preterm Newborns At Risk For Malnutrition 9/19/2016
Teva (TEVA) Strengthens Injectables Portfolio With The Launch Of An Authorized Generic Of Cubicin (Daptomycin For Injection) In The United States 9/15/2016
Duchesnay Obtains Exclusive Canadian Commercial Rights To Fluomizin, Indicated For The Treatment Of Vaginal Infections 9/13/2016
BOO! Big Pharmas Like GlaxoSmithKline (GSK), Pfizer (PFE) and Mylan (MYL) Use Scare Tactics to Drum Up Sales 9/13/2016
Valeant (VRX) And Progenics (PGNX) Announce The U.S. Commercial Launch Of FDA-Approved Relistor Tablets 9/7/2016
XTL Biopharma (XTLB) Announces The European Patent Office Has Issued A Patent For Its Lupus Drug hCDR1 9/7/2016
Shield Therapeutics Release: Composition Of Matter Patent Granted On Feraccru 9/7/2016
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Bupropion Hcl Extended-Release Tablets, USP (SR) In The U.S. Market 9/2/2016
Sanofi Genzyme (SNY) Release: Alberta Includes LEMTRADA (Alemtuzumab) On Provincial Drug Program For Eligible Patients 9/1/2016
Zambon Launches Xadago (Safinamide) In Norway For Patients With Mid- To Late-Stage Parkinson’s Disease 9/1/2016
Laboratorios SALVAT S.A. And Arbor Pharma Announce The Launch Of OTOVEL (Ciprofloxacin 0.3 % And Fluocinolone Acetonide 0.025 %) Otic Solution 8/30/2016
Backlash Leads Mylan (MYL) to Launch First Generic EpiPen at Half the Price 8/29/2016
Sanofi Genzyme (SNY) Release: New Brunswick Includes LEMTRADA (Alemtuzumab) On Provincial Drug Program For Eligible Patients 8/25/2016
GlaxoSmithKline (GSK) Best-Selling Weight Loss Pill Cramped By Problematic Studies That Understated Its Harms 8/17/2016
UCB Soars Most Since 2009 After US District Court Backs Epilepsy Drug Vimpat Patent 8/15/2016
Flamel Technologies (FLML) Launches Akovaz 8/12/2016
AstraZeneca PLC (AZN) Wins UK Cost Approval for Longer Use of Clot Buster Brilique 8/12/2016
10,000+ Women Took Sanofi (SNY)'s Anti-Epilepsy Drug Despite Risk to Fetuses 8/10/2016
Valeant (VRX) Announces Relaunch Of Generic Ofloxacin Otic Solution 8/9/2016
Wockhardt (WOCKHARDT.BO) Plunges On U.S. Ban On Third Drug-Making Factory 8/8/2016
Pharmascience Inc. Voluntarily Recalls One Lot Of Pms-Atenolol 100mg Due To A Labelling Error 8/8/2016
Teva (TEVA) Announces Launch Of Generic Gleevec Tablets In The United States 8/5/2016
Children Hospitalized Over Inno Pharma's Super Strong Vitamin D Supplement 8/5/2016
Jazz Pharma (JAZZ) Release: CMS Grants New Technology Add-On Payment To Defitelio For The Treatment Of Hepatic Veno-Occlusive Disease With Renal Or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation 8/3/2016
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ Is Now Available For The Treatment Of Non-24-Hour Sleep-Wake Disorder In Germany 8/1/2016
Mylan (MYL) Launches Generic Dexedrine Capsules 8/1/2016
Zealand Pharma  (ZEAL.CO) Release: Royalty Report For Q2 2016 And Update On Lixisenatide (Lyxumia/Adlyxintm) And Iglarlixi 7/29/2016
Shire (SHPG) Launches Pediatric Indication For Immunodeficiency Treatment Hyqvia In Europe 7/21/2016
Indonesia Begins Re-Vaccinating Victims Of Fake Drug Ring 7/18/2016
Sun Pharma (SUNPHARMA.NS) Launches Gemcitabine InfuSMART, World's First Licensed Ready-To-Administer Bag For Oncology Treatment 7/11/2016
Biofrontera AG Expands Belixos Dermo-Cosmetics Product Line With Belixos To Go 7/11/2016
Eisai Company (ESALY.PK) to Consider Legal Action in UK Cancer Drug Row 7/8/2016
Health Canada Allowing Immediate Access To Naloxone Nasal Spray 7/7/2016
Orexo (ORXOF) Welcomes Increased Access To Treatment For Patients With Opioid Dependence In The U.S. 7/7/2016
European Medicines Agency Responds to Inquiry into Allegations that Roche (RHHBY) Failed to Comply With Reporting Procedures for 19 of Its Products 7/6/2016
Drugs That Saved HIV Patients Now Threaten Them In Old Age 7/6/2016
Zambon Launches Xadago (Safinamide) In The Netherlands For Patients With Mid- To Late-Stage Parkinson’s Disease 7/6/2016
Sanofi Genzyme (SNY) Release: Saskatchewan Includes LEMTRADA (Alemtuzumab) On MS Drugs Program For Eligible Patients 7/5/2016
Otsuka Pharma Release: ORALTAG (Iohexol), A New Oral Contrast Agent For Abdominal CT Scans, Launched In U.S. 7/5/2016
This Is An Amended Media Release Further To Novartis Pharmaceuticals Canada Inc. (NVS)'s ("Novartis") Media Release Issued On January 7, 2015 For Fluad Pediatric 7/5/2016
MEC Prime - Banner Chemicals UK Is Proud To Launch The New Range Of METHYLENE CHLORIDE PRIME Products To Its European Customers 7/5/2016
A*STAR’s IME Launches Chip-On-Wafer Consortium II And Cost-Effective Interposer Consortium To Advance Chip Packaging Solutions For High-Volume Manufacturing 6/30/2016
BIOVEN: Marketing Rights To EGF-PTI In The U.S.A. 6/29/2016
Life Or Death: Why Chinese Patients Mix Drug Cocktails At Home 6/29/2016
How Brexit Is Affecting UK’s Drug Companies, Including GlaxoSmithKline (GSK), Gilead (GILD) and AstraZeneca PLC (AZN) 6/28/2016
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Launch In Japan And Provides Market Update For Kerasal Nail And Emtrix 6/28/2016
British Trade Group Suspends Astellas (ALPMY) After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors 6/27/2016
Hetero Drugs Launches Biosimilar 'Bevacizumab' For The Treatment Of Metastatic Colorectal Cancer (mCRC) Under The Brand Name 'Cizumabtm' 6/27/2016
FDA Accepts Spectral's Expanded Access Protocol For Toraymyxin 6/27/2016
In Letter to Senator Franken, FDA Defends Handling of Medtronic (MDT)'s Infuse Study 6/23/2016
Novartis AG (NVS) Pledges to Nearly Triple Biosimilar Drugs on Market By 2020 6/20/2016
SatRx LLC Announces First Registration In Russia of SatRx (gosogliptin), An Innovative Drug For Treatment Of Type 2 Diabetes 6/8/2016
Oxford Gene Technology Ltd. Enhances NGS Results From FFPE Samples 6/8/2016
Adocia Reinforces Its Focus On Diabetes With The Launch Of A New Project: BioChaperone Glucagon 6/8/2016
Cristalia Obtains Registration For First Biotechnological Pharmaceutical Ingredient 6/7/2016
Mylan (MYL) Launches Generic Cleocin Solution 6/3/2016
Roche (RHHBY) and Novartis AG (NVS) Gear Up to Battle Over Biosimilars 6/2/2016
Mylan (MYL) Launches Generic Rythmol Sustained-Release Capsules 6/2/2016
Mylan (MYL) Launches Generic Vidaza Injection 6/2/2016
Mylan (MYL) Launches First Generic of Nuvigil Tablets 6/1/2016
Takeda Pharmaceuticals U.S.A., Inc. Release: Trintellix (vortioxetine) Now Available In U.S. Pharmacies 6/1/2016
Promius Pharma, LLC Launches Sernivo (Betamethasone Dipropionate) Spray, 0.05% 6/1/2016
Delcath Systems (DCTH) Announces Launch Of CHEMOSAT At The HM Sanchinarro University Hospital In Madrid 6/1/2016
Baxter International (BAX) Unveils Innovative THERANOVA Dialyser At 2016 ERA-EDTA Congress 5/24/2016
Novartis AG (NVS)'s Entresto Boosted by Class I Recommendation in U.S., EU Heart Failure Guidelines 5/23/2016
Zambon Launches Xadago (Safinamide) In The U.K. For Patients With Mid- To Late-Stage Parkinson’s Disease 5/23/2016
Martindale Pharma Release: Prenoxad Injection Approved In Five European Countries Opening Way For Pan-European Availability Of A Take-Home Naloxone Product 5/11/2016
Sanguine Medical Ltd Release: Vivostat Co-Delivery: Cutting-Edge Burn Treatment On Trial 5/9/2016
Mylan (MYL) Launches Generic Apresoline Injection 5/5/2016
Grand Cayman Will Use Oxitec Solution To Suppress Wild Aedes Aegypti, The Dangerous Mosquito That Spreads Dengue, Zika And Chikungunya, In An Effort To Help Eliminate These Diseases 5/5/2016
Takeda Pharmaceuticals Release: Brintellix (Vortioxetine) Renamed Trintellix (Vortioxetine) In U.S. To Avoid Name Confusion 5/3/2016
Perrigo (PRGO) And Allergan (AGN) Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex 1200mg DM Extended-Release Tablets 5/3/2016
Dynavax (DVAX)'s Possible Hep B Win Could Prove a Threat to GlaxoSmithKline (GSK) 5/3/2016
Merck Canada Inc. Release: New Treatment Now Available For Canadians With Metastatic Non-Small Cell Lung Cancer 4/20/2016
Promius Pharma, LLC Release: ZEMBRACE Symtouch (Sumatriptan Injection) 3 Mg, Approved By The FDA In January 2016 For The Acute Treatment Of Migraine With Or Without Aura In Adults, Is Now Commercially Available In The U.S. 4/19/2016
PTC Therapeutics (PTCT) Release: National Institute for Clinical Excellence (NICE) Recommends Translarna (Ataluren) For The Treatment Of Patients With Nonsense Mutation Duchenne Muscular Dystrophy In England 4/15/2016
Why Chinese Parents Are Shopping For Vaccines In Hong Kong 4/13/2016
Martindale Pharma Launches First Ready-To-Use Presentation Of Phenylephrine 4/12/2016
GE Healthcare Expands European Capabilities To Support Accelerated Biomanufacturing 4/12/2016
Midatech’s Commercial Launch Of Zuplenz (Ondansetron) Oral Soluble Film To Prevent Post-Operative, Chemotherapy And Radiation-Induced Nausea And Vomiting In U.S. 4/11/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Beteflam 4/6/2016
Lupin (LUPN.BO) Launches Generic Intermezzo Sublingual Tablets In The US 4/6/2016
BTG plc (BTG.L) Announces US Launch Of LC Bead LUMI, Ground-Breaking Radiopaque Embolic Bead 4/1/2016
Biofrontera AG Release: Swiss Compulsory Health Insurance Reimburses Ameluz For Treatment Of Actinic Keratosis 4/1/2016
SELLAS Receives USAN Approval For Generic Name Of Galinpepimut-S For WT1 Vaccine, SELLAS's Late Clinical-Stage Cancer Immunotherapy Candidate 3/29/2016
7 Potential Blockbuster Drugs May Hit the Market This Year 3/28/2016
Birth Of The $1 Diarrhea Vaccine 3/28/2016
China's Vaccine Scandal Reveals System's Flaws 3/25/2016
Profounda, Inc. Launches Impavido (miltefosine), The First And Only Oral Rx Treatment For Visceral, Mucosal And Cutaneous Leishmaniasis, In The United States 3/22/2016
$90 Million China Vaccine Scandal Prompts Angry Backlash From Parents And Doctors 3/22/2016
Teva (TEVA) Announces Launch Of Generic Campral® In The United States 3/22/2016
Martindale Pharma Re-Launches Methadone Range In Scandinavia 3/21/2016
BTG International Canada Expands Operations To Directly Sell Interventional Oncology Products 3/10/2016
Teva (TEVA) Completes Generic Pulmicort Respules Portfolio With The Launch Of Third Strength In The United States 3/9/2016
Zika Virus Guidance From FDA Notes Safety Of Plasma Protein Products And The Availability Of Octapharma AG’s Octaplas 3/7/2016
How a $150,000 Drug Created with Bristol-Myers Squibb (BMY) Saved Ono Pharma 3/7/2016
Altan Pharma Announces The Launch Of Linezolid 2mg/Ml Solution For Infusion In Spain 3/3/2016
Health Canada Issues Notice Of Compliance For Gilead (GILD)'s Truvada For Reducing The Risk Of Sexually Acquired HIV Infection 2/29/2016
Zambon Launches Xadago (Safinamide) In Italy For Patients With Mid- To Late-Stage Parkinson’s Disease 2/29/2016
Adapt Pharma Release: NARCAN (Naloxone Hydrochloride) NASAL SPRAY Now Available In The United States For Emergency Treatment Of Known Or Suspected Opioid Overdose 2/26/2016
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine Recognized As A New Option With Demonstrated Superior Efficacy* For Adults 65 Years And Older 2/24/2016
Sanofi US (SNY) To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo 2/24/2016
GlaxoSmithKline (GSK) President’s "Eight Terrifying Words" Face Systemic Challenges in U.S. 2/24/2016
CSL Behring Release: First Export Of Privigen From New Manufacturing Facility In Broadmeadows, Melbourne, Australia 2/23/2016
Merck Canada Inc. Release: New Antibiotic Against Drug-Resistant Bacteria Now Available 2/22/2016
Lipogen Ltd. Targets PMS/PMDD Relief, Naturally 2/22/2016
Specialised Therapeutics Asia To Distribute Novel Multiple Myeloma Drug APLIDIN In South East Asia, Australia And New Zealand 2/3/2016
Lupin (LUPN.BO) Launches Generic Glumetza HCI ER Tablets In The US 2/2/2016
Sinovac Biotech Ltd. (SVA) Announces Issuance Of GMP Certificate For EV71 Vaccine 1/28/2016
Teva (TEVA) And Eagle Pharma (EGRX) Announce Commercial Availability Of BENDEKA (Bendamustine Hydrochloride) Injection 1/28/2016
Cardiome Pharma Corp. (COM.TO) Announces The Launch Of ESMOCARD LYO In Belgium 1/21/2016
Off Label Use of Roche (RHHBY)’s Avastin in India Puts 15 in the Hospital, Prompts Officials to Halt Using the Drug 1/21/2016
Mylan (MYL) Launches Generic Harvoni (Ledipasvir/Sofosbuvir) Under The Brand Name Myhep LVIR In India 1/7/2016
EffRx: First-In-Class Osteoporosis Treatment Binosto Launches In South Korea 1/7/2016
Lupin (LUPN.BO) Launches Generic Ortho Tri-Cyclen Lo Tablets In The US 1/6/2016
Mylan (MYL) Launches Generic Ortho Tri-Cyclen Lo Tablets 1/5/2016
Teva (TEVA) Announces Launch Of Generic Ortho Tri-Cyclen Lo In The United States 1/5/2016
Bioventus Launches DUROLANE For Osteoarthritis Patients In Taiwan 1/4/2016
Turing Release: Continued Availability Of Daraprim (pyrimethamine) 12/21/2015
Pharming And Hyupjin Announce Receipt Of The South Korean Marketing Authorization For RUCONEST 12/21/2015
TaiGen Biotechnology Launches Taigexyn In Taiwan 12/16/2015
Endo International (ENDP) Announces Extension Of U.S. Rights For Voltaren Gel 12/14/2015
ALK-Abello A/S Release: New Product Product (ACARIZAX) For For Treatment Of House Dust Mite Allergic Rhinitis And Asthma Obtains Reimbursement In Denmark 12/9/2015
Veloxis Pharmaceuticals A/S (VELO) Launches EnvarsusXR For Treatment Of Kidney Transplant Patients In U.S. 12/7/2015
United Laboratories Inc. And Debiopharm Announce The Launch Of Pamorelin LA In The Philippines 12/7/2015
Ruizhida From China Launched Its New Line Of Acne Treatment Products 12/3/2015
Bio Products Laboratory Announces Supply Of COAGADEX Now Available In The United States 12/3/2015
Sanofi (SNY) Creeps Up On Biogen (BIIB)’s MS Market Share 12/2/2015
TB Alliance And Partners Announce World's First Availability Of Appropriate, Child-Friendly TB Medicines In Correct Doses 12/2/2015
Mesoblast (MSB.AX)’s Japan Licensee Receives Pricing For TEMCELL HS Inj. For Treatment Of Acute Graft Versus Host Disease 11/30/2015
Mylan (MYL) Launches Generic FazaClo Orally Disintegrating Tablets 11/24/2015
Cumberland Pharmaceuticals (CPIX) Release: Caldolor Launched In Australia For Treatment Of Pain And Fever 11/24/2015
CVS Picks Amgen (AMGN)'s Repatha Over Sanofi (SNY)-Regeneron (REGN)'s Cholesterol Drug 11/23/2015
Mylan (MYL) Launches Generic AXERT Tablets 11/17/2015
AstraZeneca PLC (AZN)'s Lung Cancer Pill and Its Hefty Price Tag 11/17/2015
Mylan (MYL) Launches Generic Viramune XR Extended-Release Tablets, 100 mg 11/16/2015
Novartis AG (NVS)'s Japanese Unit in Trouble Again for Failing to Report Drug Side Effects on Time 11/12/2015
Mallinckrodt (MNK) Plunges After Citron Claims Next Victim in Tweet 11/11/2015
Pfizer Canada Inc. Release: Update on Availability Of EpiPen (epinephrine) Auto-Injectors For Canadian Patients 11/9/2015
Admedus Announces Launch Of Cardiocel In Malaysia 11/4/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared 11/4/2015
Bespak plc (BPK.L) Launches Syrina 2.25 Auto Injector And Leads Industry Workshop On Innovation In Combinational Products At PDA Europe 11/2/2015
Mylan (MYL) Confirms Availability of EpiPen (epinephrine injection) Auto-Injector For U.S. Patients Affected By Sanofi (SNY)'s Auvi-Q (Epinephrine Injection, USP) Recall 10/30/2015
AstraZeneca Canada (AZN) Release: DUAKLIR GENUAIR Now Available In Canada For The Treatment Of Chronic Obstructive Pulmonary Disease 10/29/2015
BioPharm Executive: From Bad to Worse: Biotech's Next Political Headache? 10/29/2015
Oasmia Executes First Commercial Order Of Paclical For The Russian Market 10/28/2015
Bavarian Nordic (BAVA.CO) Announces Expansion Of IMVAMUNE Orders From Canadian Government 10/28/2015
Mundipharma AG Release: Green Whistle Receives Regulatorry And Marketing Approval In The United Kingdom 10/28/2015
Novozymes Release: New Enzyme Boosts Profits, Cuts Chemical Use At Ethanol Plants 10/27/2015
AstraZeneca Canada (AZN) Launches New FluMist® Quadrivalent Flu Vaccine For This Flu Season 10/26/2015
The Native Antigen Company Limited (‘NAC’: Oxford, UK) Announces The Launch Of A New Range Of Dengue Virus-Like Particles Incorporating Products For All Four Dengue Serotypes. 10/22/2015
Hired By Huge Drug Companies Like Eli Lilly (LLY), Ex-Cop in London Tracks Down Knockoff Drugs on the Web 10/21/2015
Allergan (AGN) Expands Dry Eye Portfolio With Launch Of REFRESH OPTIVE Gel Drops 10/21/2015
Teva (TEVA) Announces Exclusive Launch Of Generic Avodart Capsules In The United States 10/12/2015
Oasmia Announces Commercial Launch Of Paclical In Russia And CIS Countries 10/5/2015
Roche Canada Release: Biologic Treatment Option Now Available To Canadian Women Living With Advanced Ovarian Cancer 10/5/2015
Lupin (LUPN.BO) Hikes Diabetes Drug Price by 200% in the U.S. 9/25/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries 9/24/2015
Complaints for Bayer AG (BAYZF)'s Sterility Device Spike Nearly 1,400% in Three Years 9/22/2015
Turing Pharma’s Toxoplasmosis Treatment Spikes 5,000% Overnight 9/22/2015
ibidi Product News: Ibidi µ-Slide 8 Well Grid-500: Track Down Your Cells In A µ-Slide 8 Well 9/21/2015
Information Update - Health Canada Proposes Revised Labelling Standard For Non-Prescription Acetaminophen Products 9/16/2015
Mylan (MYL) Launches Generic Unasyn For Injection 9/14/2015
Allergan (AGN) Expands Access To IUDs For Millions Of Underserved Women In The US By Announcing Agreement With Apexus For Nationwide Distribution Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg 9/10/2015
Vernalis Therapeutics Launches Long-Acting Codeine-Based Cough Suppressant Ahead Of U.S. Cough Cold Season 9/8/2015
Roche (RHHBY) Chief Blasts U.K. Decision to Not Cover Costs of Some Cancer Treatments 9/8/2015
Novartis AG (NVS) Takes on Amgen (AMGN) With Launch of the First U.S. Biosimilar 9/4/2015
Allergan (AGN) Announces FDA Approval Of Updated Label For TEFLARO (ceftaroline fosamil) 9/2/2015
Laccure's Antibiotic-Free OTC Product For Bacterial Vaginosis Ready For Commercialisation 9/1/2015
Teva (TEVA) Announces U.S. Availability Of ZECUITY (Sumatriptan Iontophoretic Transdermal System), First And Only Transdermal Patch System For The Acute Treatment Of Migraine 9/1/2015
Endo Pharmaceuticals (ENDP) Announces XIAFLEX For Dupuytren's Contracture Formal Pricing In Japan; Commercial Launch Set For September 16, 2015 8/31/2015
BioSpecifics Technologies Corporation (BSTC) Announces Formal Pricing Of XIAFLEX For The Treatment Of Dupuytren's Contracture In Japan 8/31/2015
Generex Biotechnology Corporation (GNBT) Announces Issuance of Buccal Insulin White Paper 8/27/2015
ReproCELLl: Joint Press Announcement With Institute For Frontier Medical Sciences, Kyoto University 8/26/2015
Hospira Release: TGA Approves First mAb Biosimilar 8/20/2015
Endo International (ENDP) Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property 8/17/2015
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets 8/12/2015
Fight Intensifying Over Which Patients Will Get Regeneron (REGN), Sanofi (SNY)'s $15,000 a Year Cholesterol Drug 8/12/2015
Innova Biosciences Introduces Range Of Conjugated Antibodies 8/10/2015
Watchdog Accuses Pfizer (PFE) of Overcharging By Millions for Epilepsy Drug 8/6/2015
Hetero Announces The Launch Of Biosimilar Rituximab (MABALL) In India 8/5/2015
Omeros Corporation (OMER) Release: Omidria Approved For Commercialization Throughout The European Union And Additional Countries 8/3/2015
Boehringer Ingelheim Welcomes The Inclusion Of OFEV (Nintedanib*) In The Updated International Treatment Guidelines For Idiopathic Pulmonary Fibrosis (IPF) 7/15/2015
Daiichi Sankyo Release: New Therapy To Help Heart Rhythm Patients Means Doctors Are "Spoilt For Choice" 7/10/2015
SANTEN Launches TAPTIQOM Preservative-Free Fixed Combination Eye Drops In The UK 7/10/2015
EXCLUSIVE: Ironwood (IRWD), AstraZeneca PLC (AZN) IBS-C Drug Will File in China Next Year, CEO Tells BioSpace (DHX) 7/9/2015
Teva (TEVA) First To Receive Approval And Launch Generic Axert Tablets In The United States 7/9/2015
Consumer Watchdog Asks FDA to Revoke Approval of Sanofi (SAN.PA)'s Seprafilm 7/8/2015
Novo Nordisk A/S (NVO) Pulls Tresiba Off Shelves in Germany 7/2/2015
Teva (TEVA) Launches Generic Aggrenox Capsules In The United States 7/1/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Polydrug Laboratories Due To Data Integrity Concerns 6/25/2015
TissueGene, Inc. Announces FDA Acceptance Of Invossa As Proprietary Name For TissueGene-C 6/24/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Zhejiang Hisun Pharma Due To Data Integrity Concerns 6/16/2015
Pfizer Consumer Healthcare (PFE) Breaks Ground On $95 Million China Facility 6/15/2015
Mylan (MYL) Launches First Bioequivalent Alternative To Combination Asthma Therapy Seretide Evohaler (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla In The UK 6/8/2015
Mylan (MYL) Launches Generic Version Of Seasonique Tablets 6/3/2015



//-->